Commitment COM-063
Post-approval commitment for PMDA-2022-0063. Category: REMS. Priority: medium.
Commitment ID
COM-063
Application
Authority
Pharmaceuticals and Medical Devices Agency
Category
REMS
Priority
medium
Status
In Progress
Due Date
2025-09-04
Completed At
—
Owner
Tomoko Ikeda
Created
2022-09-22
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.